{"id":"https://openalex.org/W2139367713","doi":"https://doi.org/10.1016/0883-2889(92)90170-j","title":"Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89","display_name":"Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89","publication_year":1992,"publication_date":"1992-12-01","ids":{"openalex":"https://openalex.org/W2139367713","doi":"https://doi.org/10.1016/0883-2889(92)90170-j","mag":"2139367713","pmid":"https://pubmed.ncbi.nlm.nih.gov/1334954"},"language":"en","primary_location":{"id":"doi:10.1016/0883-2889(92)90170-j","doi":"https://doi.org/10.1016/0883-2889(92)90170-j","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0883-2889(92)90170-j","pdf_url":null,"source":{"id":"https://openalex.org/S198311341","display_name":"International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes","issn_l":"0883-2889","issn":["0883-2889","1878-1128"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320146","host_organization_name":"Pergamon Press","host_organization_lineage":["https://openalex.org/P4310320146"],"host_organization_lineage_names":["Pergamon Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065771560","display_name":"Wilma E. Meijs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wilma E. Meijs","raw_affiliation_strings":["Radio-Nuclide-Centre (RNC), Free University, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radio-Nuclide-Centre (RNC), Free University, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110038802","display_name":"Jacobus D. M. Herscheid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jacobus D.M. Herscheid","raw_affiliation_strings":["Radio-Nuclide-Centre (RNC), Free University, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radio-Nuclide-Centre (RNC), Free University, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021729725","display_name":"Hidde J. Haisma","orcid":"https://orcid.org/0000-0003-3997-9052","observed_orcids":["https://orcid.org/0000-0003-3997-9052"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hidde J. Haisma","raw_affiliation_strings":["Department of Oncology, Free University Hospital, Amsterdam, The Netherlands","Pharmaceutical Gene Modulation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]},{"raw_affiliation_string":"Pharmaceutical Gene Modulation","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105878379","display_name":"Herbert M. Pinedo","orcid":"https://orcid.org/0000-0002-8980-371X","observed_orcids":["https://orcid.org/0000-0002-8980-371X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herbert M. Pinedo","raw_affiliation_strings":["Department of Oncology, Free University Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.913,"has_fulltext":false,"cited_by_count":143,"citation_normalized_percentile":{"value":0.77459632,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"43","issue":"12","first_page":"1443","last_page":"1447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11279","display_name":"Lanthanide and Transition Metal Complexes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zirconium-89","display_name":"zirconium-89","score":0.8970000147819519},{"id":"https://openalex.org/keywords/antibody-labeling","display_name":"antibody labeling","score":0.7020000219345093},{"id":"https://openalex.org/keywords/bifunctional-chelating-agents","display_name":"bifunctional chelating agents","score":0.9419999718666077},{"id":"https://openalex.org/keywords/radiolabeled-antibodies","display_name":"radiolabeled antibodies","score":0.6710000038146973},{"id":"https://openalex.org/keywords/in-vitro-stability","display_name":"in vitro stability","score":0.6549999713897705},{"id":"https://openalex.org/keywords/plasma-stability","display_name":"plasma stability","score":0.8460000157356262}],"concepts":[{"id":"https://openalex.org/C534791751","wikidata":"https://www.wikidata.org/wiki/Q1038","display_name":"Zirconium","level":2,"score":0.8162758350372314},{"id":"https://openalex.org/C197404232","wikidata":"https://www.wikidata.org/wiki/Q319827","display_name":"Chelation","level":2,"score":0.8116379976272583},{"id":"https://openalex.org/C2780443040","wikidata":"https://www.wikidata.org/wiki/Q3737863","display_name":"Bifunctional","level":3,"score":0.6845513582229614},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.601048469543457},{"id":"https://openalex.org/C144082473","wikidata":"https://www.wikidata.org/wiki/Q213185","display_name":"Stoichiometry","level":2,"score":0.5784939527511597},{"id":"https://openalex.org/C66974803","wikidata":"https://www.wikidata.org/wiki/Q10359898","display_name":"Nuclear magnetic resonance spectroscopy","level":2,"score":0.47363677620887756},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.4346110224723816},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.33189940452575684},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.16289940476417542},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12525847554206848},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.09554260969161987}],"mesh":[{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002614","descriptor_name":"Chelating Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003676","descriptor_name":"Deferoxamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005069","descriptor_name":"Evaluation Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007553","descriptor_name":"Isotope Labeling","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D011868","descriptor_name":"Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015040","descriptor_name":"Zirconium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/0883-2889(92)90170-j","doi":"https://doi.org/10.1016/0883-2889(92)90170-j","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0883-2889(92)90170-j","pdf_url":null,"source":{"id":"https://openalex.org/S198311341","display_name":"International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes","issn_l":"0883-2889","issn":["0883-2889","1878-1128"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320146","host_organization_name":"Pergamon Press","host_organization_lineage":["https://openalex.org/P4310320146"],"host_organization_lineage_names":["Pergamon Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes","raw_type":"journal-article"},{"id":"pmid:1334954","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1334954","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/68e5fcbd-6c37-401b-8504-771ffef82410","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/68e5fcbd-6c37-401b-8504-771ffef82410","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"MEIJS, WE, HERSCHEID, JDM, Haisma, H & PINEDO, HM 1992, 'EVALUATION OF DESFERAL AS A BIFUNCTIONAL CHELATING AGENT FOR LABELING ANTIBODIES WITH ZR-89', Applied Radiation and Isotopes, vol. 43, no. 12, pp. 1443-1447.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/68e5fcbd-6c37-401b-8504-771ffef82410","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/68e5fcbd-6c37-401b-8504-771ffef82410","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Applied Radiation and Isotopes, 43(12), 1443 - 1447. PERGAMON-ELSEVIER SCIENCE LTD","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1515308980","https://openalex.org/W1978880031","https://openalex.org/W1987750048","https://openalex.org/W1996564102","https://openalex.org/W2003613730","https://openalex.org/W2008880810","https://openalex.org/W2026098269","https://openalex.org/W2026918336","https://openalex.org/W2034609927","https://openalex.org/W2039413306","https://openalex.org/W2051437643","https://openalex.org/W2051572294","https://openalex.org/W2060039676","https://openalex.org/W2072453420","https://openalex.org/W2076926879","https://openalex.org/W2595776066","https://openalex.org/W2608596399","https://openalex.org/W4205856630","https://openalex.org/W6645098650","https://openalex.org/W6665600604","https://openalex.org/W6736571924"],"related_works":["https://openalex.org/W3114749440","https://openalex.org/W3045827062","https://openalex.org/W2735286575","https://openalex.org/W3020841146","https://openalex.org/W2096862409","https://openalex.org/W2071402361","https://openalex.org/W2953113650","https://openalex.org/W4405226359","https://openalex.org/W4365483257","https://openalex.org/W1501928045"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}